TITLE

Ultrasound diagnosed adenomyosis has a negative impact on successful implantation following GnRH antagonist IVF treatment

AUTHOR(S)
Thalluri, V.; Tremellen, K.P.
PUB. DATE
December 2012
SOURCE
Human Reproduction;Dec2012, Vol. 27 Issue 12, p3487
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
STUDY QUESTION Does the presence of ultrasound diagnosed adenomyosis interfere with successful implantation in patients undergoing IVF treatment with GnRH antagonist ovarian stimulation? SUMMARY ANSWER The presence of ultrasound diagnosed adenomyosis was associated with a significant reduction in successful implantation of good quality embryos in patients undergoing GnRH antagonist stimulation for IVF treatment (viable clinical pregnancy rate 23.6% versus 44.6%, P= 0.017). WHAT IS KNOWN AND WHAT THIS PAPER ADDS There is currently no consensus regarding the impact of adenomyosis on implantation potential. Although some studies have identified alterations in the endometrial milieu in adenomyosis patients that may impact implantation, several papers have reported no associated reproductive deficit. However, these pregnancy outcome studies have primarily investigated patients undergoing long down-regulation IVF protocols, where low levels of serum estrogen (before commencing the ovarian stimulation) may inactivate the adenomyosis and potentially negate its effect on implantation. Given that the majority of fertility clinics are now moving towards the more ‘patient-friendly’ antagonist protocol, where patients are not placed in a hypo-estrogen state before commencing ovarian stimulation, the question of whether adenomyosis has an impact on IVF success rates in GnRH antagonist-stimulated IVF treatment needs to be examined. DESIGN This is a retrospective cohort study of 748 patients who, between April 2010 and March 2012, underwent a screening transvaginal ultrasound to identify possible pelvic pathology before commencing their IVF treatment. From this screening group, 213 patients were eligible to be included in the study as they had no obvious underlying uterine or embryonic factors that could have interfered with successful implantation (aged ≤39 years, good quality Day 4/5 embryo for single-embryo transfer, no uterine fibroids/hydrosalpinx or endometrial polyps). PARTICIPANTS AND SETTING There were 213 patients in a private IVF unit eligible to be included in the study, with 38 patients (17.84%) having ultrasound diagnosed adenomyosis and 175 patients having no adenomyosis on the scan. Only the first treatment cycle for each patient was included. MAIN RESULTS AND THE ROLE OF CHANCE The adenomyosis group had a viable clinical pregnancy rate of 23.6% compared with 44.6% in the non-adenomyosis group (P =0.017). However, the median maternal age and duration of infertility of the adenomyosis group was 2 years older and 4 months greater, respectively, than that of the non-adenomyosis group. A logistic regression analysis was performed to account for these differences between the two groups, with the adjusted results still showing a statistically significant decline in viable pregnancy rate in the adenomyosis group (OR = 0.408, CI = 0.181–0.922, P =0.031 when adjusting for maternal age; OR = 0.417, CI = 0.175–0.989, P =0.047 when adjusting for duration of infertility) BIAS, CONFOUNDING AND OTHER REASONS FOR CAUTION Given the retrospective nature of this study, there is risk of bias. This risk was minimized by having subjective variables such as embryo quality assessed by individuals not involved in the study, while strictly applying the pre-determined inclusion/exclusion criteria to all study participants. Furthermore, it is acknowledged that ultrasound isnot a perfect test for the diagnosis of adenomyosis and, therefore, may underestimate the incidence of adenomyosis by misclassifying some patients with mild adenomyosis as not affected. WIDER IMPLICATIONS OF THE FINDINGS The results of this study should be representative of outcomes for any patient undergoing a GnRH antagonist ovarian stimulation cycle for IVF since standard IVF treatment ...
ACCESSION #
83746524

 

Related Articles

  • IVF-Patients With Nonmale Factor 'To ICSI' or 'Not to ICSI' That is the Question? Poehl, Michaela; Holagschwandtner, Maria; Bichler, Katherina; Krischker, Ulrike; Jurgen, Spona; Feichtinger, Wilfried // Journal of Assisted Reproduction & Genetics;Apr2001, Vol. 18 Issue 4, p205 

    Examines the potential benefit of intracytoplasmic sperm injection (ICSI) in infertile in vitro fertilization (IVF) patients without male factor. Percentage of pregnancy rates in the normal IVF group and the ICSI group; Percentage of implantation rates per transferred embryo; Percentage of...

  • MicroRNAs are associated with human embryo implantation defects. Revel, Ariel; Achache, Hanna; Stevens, Juliet; Smith, Yoav; Reich, Reuven // Human Reproduction;Oct2011, Vol. 26 Issue 10, p2830 

    Background: Repeated implantation failure (RIF) is a major problem encountered in IVF. We have previously reported that RIF-IVF patients have a different endometrial gene expression profile during the window of implantation. Considering microRNA (miRNA) function in...

  • INVITED SESSION, SESSION 66: SREI/ASRM EXCHANGE SESSION - TREATMENT OPTIONS FOR PCOS Wednesday 6 July 2011 12:00 - 13:00.  // Human Reproduction;Jan2011 Supplement 1, Vol. 26 Issue suppl_1, pi104 

    No abstract available.

  • Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies. Refaat, Bassem; Dalton, Elizabeth; Ledger, William L. // Reproductive Biology & Endocrinology;2015, Vol. 13 Issue 1, p1 

    Background: Ectopic pregnancy (EP) is the leading cause of maternal morbidity and mortality during the first trimester and the incidence increases dramatically with in vitro fertilisation and embryo transfer (IVF-ET). The co-existence of an EP with a viable intrauterine pregnancy (IUP) is known...

  • Poor Receptivity in Homogeneous Endometrium in Late Follicular Phase of Natural Cycle.  // Fertility Weekly;9/2/2013, p12 

    The article discusses the study by Wenjie Zhue and colleagues which examines homogeneous endometrium receptivity in the late follicular phase in infertile women with natural cycles. The study performs edometrial biopsies on a total of 28 infertile women with either trilaminar endometrium or...

  • Coculture with homologous oviductal cells improved the implantation of human embryos--a... Yeung, William S.B.; Lau, Estella Y.L. // Journal of Assisted Reproduction & Genetics;Nov96, Vol. 13 Issue 10, p762 

    Investigates the efficacy of homologous oviductal cell coculture on the success of a human in vitro fertilization (IVF). Incidence of implantation in various age groups; Demonstration that human oviductal cells improved the implantation of embryos; Indication that coculture would improve the...

  • Cook Versus Edwards-Wallace: Are There Differences in Flexible Catheters? Boone, William R.; Johnson, Jane E.; Blackhurst, Dawn M.; Crane IV, Martin M. // Journal of Assisted Reproduction & Genetics;Jan2001, Vol. 18 Issue 1, p15 

    Compares clinical pregnancy rates after embryo transfer with the Cook soft-pass catheter and the Edwards-Wallace catheter. Characteristics of patients by assigned catheter group; Pregnancy rates in in vitro production programs by type of embryo transfer catheter.

  • Emergency Sperm Extraction for Transient Erectile Dysfunction Prior to Assisted Conception. Ojha, Kamal; Nargund, Vinod; Nargund, Geeta // Journal of Assisted Reproduction & Genetics;Jan2001, Vol. 18 Issue 1, p34 

    Examines the use of emergency percutaneous epididymal sperm aspiration for temporary erectile dysfunction in a couple undergoing in vitro fertilization. Spermatozoa for intracytoplasmic sperm injection; Ilioinguinal, genitofemoral and pudendal nerve block with lignocaine and marcaine;...

  • Is intracytoplasmic sperm injection necessary for couples undergoing in vitro fertilization... Surrey, Eric S.; Lee, Grace S. // Journal of Assisted Reproduction & Genetics;Feb99, Vol. 16 Issue 2, p69 

    Assesses whether in vitro fertilization-embryo transfer candidate couples with basically normal semen analyses benefit from intracytoplasmic sperm injection. Failure in zona-free hamster egg penetration assay scores; Fertilization and cleavage rates for candidate couples.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics